Abstract
Guillain–Barre syndrome (GBS) is the leading cause of acute paralysis that can potentially
affect all of the human population. GBS is believed to be an immune-mediated disease,
possibly triggered by a recent infection, and driven by an immune attack targeting
the peripheral nervous system. GBS can be divided into several subtypes depending
on the phenotype, pathophysiology, and neurophysiological features. Unfortunately,
morbidity and mortality rates are still high despite the current understanding of
the pathophysiology and available treatment options. Additional research is still
needed to shed more light into the pathogenesis for a better understanding and treatment
of this condition.
Keywords
Guillain–Barre syndrome - acute inflammatory demyelinating polyneuropathy - acute
motor axonal polyneuropathy - Miller–Fisher syndrome
